MiNK Therapeutics, Inc.
INKT
$8.41
-$0.34-3.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.78M | -13.78M | -17.09M | -20.59M | -22.46M |
| Total Depreciation and Amortization | 215.40K | 215.10K | 206.00K | 212.80K | 204.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 554.20K | 952.90K | 3.08M | 3.27M | 3.59M |
| Change in Net Operating Assets | 459.80K | 1.75M | 1.72M | 3.17M | 2.90M |
| Cash from Operations | -9.56M | -10.86M | -12.08M | -13.94M | -15.76M |
| Capital Expenditure | -- | 0.00 | -23.00K | -60.00K | -73.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | -23.00K | -60.00K | -73.50K |
| Total Debt Issued | 5.00M | 5.00M | 5.00M | 5.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.82M | 5.82M | 5.82M | 31.90K | 70.50K |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -97.70K | -477.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.82M | 10.82M | 10.82M | 4.93M | -407.10K |
| Foreign Exchange rate Adjustments | -54.60K | -26.80K | -23.60K | -10.70K | -25.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.21M | -70.50K | -1.31M | -9.07M | -16.27M |
